According to a new report by Polaris Market Research, the global mice model market was valued at USD 1.36 billion in 2023 and is projected to reach USD 2.68 billion by 2032, expanding at a CAGR of 7.8% over the forecast period. Growth is underpinned by rising demand for personalized medicine, expanding biomedical research investment, and accelerating genomic technology adoption across pharmaceutical and academic research.

What Is Driving Mice Model Market Growth?

Demand is climbing as advances in genomics converge with rising investment in biomedical research. Pharmaceutical companies and research institutes are prioritizing genetically modified mouse strains, pushing mice model adoption across preclinical drug development and disease-mechanism studies worldwide. Polaris analysts note that gene-editing technologies such as CRISPR/Cas9 have revolutionized the creation of genetically engineered models, positioning the segment for sustained growth through 2032, with pharmaceutical and biotechnology companies emerging as the largest end-user contributor and the oncology application posting significant incremental gains.

Key Trends Shaping the Mice Model Industry

CRISPR and Genomic Technology Advancement

Techniques such as CRISPR/Cas9 gene editing, next-generation sequencing, and genome-wide association studies are enabling faster, more precise creation of genetically engineered mice, weaving technology advancement into personalized-medicine research pipelines.

Regulatory and Ethical Compliance Landscape

Stringent animal-welfare regulations and research-ethics requirements govern the use of mice models globally, shaping the regulatory landscape as researchers navigate housing, care, and experimentation guidelines that vary across regions.

Strategic Partnerships and Biomedical Investment

Rising investments in biomedical research from governments, academic institutions, and pharmaceutical companies are shifting the competitive landscape, with market outlook increasingly shaped by cross-border distribution partnerships for validated mouse models.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

https://www.polarismarketresearch.com/industry-analysis/mice-model-market 

Market Segmentation: Breaking Down the Mice Model Market

Polaris segments the mice model market by model and service, end user, application, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Model and Service

The Model segment held a significant mice model market share in 2023 due to its versatile applications across disease modeling, drug discovery, and toxicology studies, supported by customization options and diverse species choices that cater to a broad range of research needs.

By End User

The Pharmaceutical and Biotechnology Companies segment held a significant share in 2023, as these firms extensively rely on mice models for drug development, safety evaluation, and personalized-medicine research, with regulatory compliance requirements further driving demand for preclinical testing.

By Application

The Oncology segment held a significant mice model market share in 2023, fueled by the global prevalence of cancer and the need for diverse mouse models tailored to cancer subtypes, playing a critical role in the preclinical testing of potential cancer therapies.

Regional Outlook: Where Is Mice Model Growing Fastest?

North America dominated the global market in 2023 on the back of advanced research infrastructure, prestigious universities, and substantial government funding, alongside technological advancements like CRISPR/Cas9 that enhance model precision. Asia-Pacific demand is expected to increase during the forecast period, driven by rapidly expanding biomedical research, rising healthcare infrastructure investment, and a growing pharmaceutical and biotechnology industry across the region.

Competitive Landscape: Leading Mice Model Companies

Key players profiled in the report include Charles River Laboratories International, Inc., Cyagen Biosciences Inc., Envigo, genOway S.A., Harbour Biomed, Hera Biolabs, Inotiv, Janvier Labs, Ozgene Pty Ltd., PolyGene, Sage Labs, Taconic Biosciences, Inc., The Jackson Laboratory, and Trans Genic Inc., who are focusing on partnerships, product-range expansion, and collaborative research ventures to strengthen market position across the Model and Oncology segments outlined above. Recent moves include Taconic Biosciences' August 2025 partnership with Cyagen to offer streamlined access to more than 16,000 genetically engineered mouse and rat models, and The Jackson Laboratory's October 2024 strategic collaboration to accelerate CRISPR-based mouse model development for rare genetic diseases.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the mice model market forecast, this report benchmarks market share, segment-level pricing, and forecast data — by model and service, end user, application, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking genetically engineered mice as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

glp-1-market

air-fryer-market

biostimulants-market

top-10-companies-in-hospital-information-system-software-market-to-know-in-2025

in-vitro-diagnostics-market

automotive-wiring-harness-market

fire-alarm-and-detection-market

semiconductor-manufacturing-equipment-market

engineered-stone-market